At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
Botulinum Toxin, Type A +2 moredrug
Likely dose
Botulinum Toxin, Type A 20 unitsfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Strain Gauge Feasibility Assessment & Correlation With Compound Muscle Action Potential & Surface Electromyogram Parameters Before & After a Single Intramuscular Injection of Botulinum Toxin Type A Into Extensor Digitorum Brevis Muscle
In Brief
A clinical study evaluating Botulinum Toxin, Type A and Saline for Muscle Strength and Botulinum Toxins, Type A. Completed, enrolled 13 participants across 2 sites.
Detailed Summary
The purpose of this feasibility study is to determine if temporary weakness of a small foot muscle caused by local injection of botulinum toxin into that muscle can be measured with a strain gauge in addition to the previously known valid measurements via nerve conduction studies and surface electromyogram.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMuscle Strength, Botulinum Toxins, Type A
CountriesUnited States
CollaboratorsAllergan
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
First PostedJan 2009
Primary CompletionMar 2009
Study CompletionJul 2015
TodayJul 2026
First PostedJan 14, 2009
Enrollment StartJan 1, 2009
Primary CompletionMar 1, 2009
Study CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.5 years ago
Interventions
Botulinum Toxin, Type Adrug
20 units, single dose, intramuscular in right EDB muscle
Botulinum Toxin, Type Adrug
2 units, single dose, intramuscular to right EDB muscle
Salinedrug
Single Dose, Intramuscular into right EDB muscle